Niagen Bioscience (NAGE)

• Market cap: $589M
• 1 day: 1.51%
• 5 days: 0.41%
• 1 month: -25.45%
• 3 months: -23.6%
• 6 months: -5.14%
• Year to date: 34.67%
• 1 year: 103.87%
• 5 years: 59.4%
• 10 years: 64.73%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 104